| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/19/2007 | US20070166755 Detecting autosomal dominant polycystic kidney disease; detecting the presence of nucleotide sequence alterations; mutation analysis of a target nucleic acid |
| 07/19/2007 | US20070166752 Compositions and Methods for Nucleic Acid Extraction from Biological Samples |
| 07/19/2007 | US20070166751 Compositions and Methods for Nucleic Acid Extraction from Biological Samples |
| 07/19/2007 | US20070166750 Compositions and Methods for Nucleic Acid Extraction from Biological Samples |
| 07/19/2007 | US20070166747 Methods for Measuring Therapy Resistance |
| 07/19/2007 | US20070166746 Human cytokine receptor |
| 07/19/2007 | US20070166745 Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins |
| 07/19/2007 | US20070166742 Nucleic acid ligand diagnostic biochip |
| 07/19/2007 | US20070166737 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 07/19/2007 | US20070166734 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 07/19/2007 | US20070166727 Genetic analysis and authentication |
| 07/19/2007 | US20070166724 Micrornas and related nucleic acids |
| 07/19/2007 | US20070166720 Small interfering RNA libraries and methods of synthesis and use |
| 07/19/2007 | US20070166719 Novel modular type II restriction endonuclease, cspci, and the use of modular endonucleases for generating endonucleases with new specificities |
| 07/19/2007 | US20070166716 Method for evaluating rnai activity and mirna activity |
| 07/19/2007 | US20070166708 Methods for detection and quantification of analytes in complex mixtures |
| 07/19/2007 | US20070166704 Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways |
| 07/19/2007 | US20070166701 Methods for detecting flavivirus infection |
| 07/19/2007 | US20070166696 Adenovirus-transfected primary cells and methods of pathway mapping |
| 07/19/2007 | US20070166367 Adept or gdept producing acetaldehyde |
| 07/19/2007 | US20070166366 Autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells |
| 07/19/2007 | US20070166334 Coccidiosis Vaccines |
| 07/19/2007 | US20070166333 Method of antigen incorporation into neisseria bacterial outer membrane vesicles and resulting vaccine formulations |
| 07/19/2007 | US20070166332 A di-chain loop region modification comprising a Clostridial toxin substrate cleavage site from a SNARE protein within the di-chain loop region that is proteolytically cleaved by the enzymatic domain of the recombinantly modified Clostridial toxin; cell expression includes single to di-chain conversion |
| 07/19/2007 | US20070166330 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 07/19/2007 | US20070166329 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 07/19/2007 | US20070166328 Genetic immunization against cervical carcinoma |
| 07/19/2007 | US20070166318 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| 07/19/2007 | US20070166314 EpA2 monoclonal antibodies and methods of use thereof |
| 07/19/2007 | US20070166312 Antibody against tumor specific antigen as target |
| 07/19/2007 | US20070166310 prostate cancer and benign prostatic hyperplasia; promote tissue regeneration and to facilitate wound healing |
| 07/19/2007 | US20070166296 Therapeutic Systems |
| 07/19/2007 | US20070166293 Supporting cell differentiation in culture with a genetical modified cells; use for gene therapy; supporters being genetically modified in order to provide externally regulatable interactions between the supporters and the stem cells; supporters and stem cells are interchangeable upon modification |
| 07/19/2007 | US20070166291 Cell preparation |
| 07/19/2007 | US20070166287 Oncolytic virus |
| 07/19/2007 | US20070166286 Self-rearranging DNA vectors |
| 07/19/2007 | US20070166284 Therapeutic regimen for treating cancer |
| 07/19/2007 | US20070166230 Ion channel |
| 07/19/2007 | DE10309803B4 α-Amylase-Varianten mit verbesserter Alkaliaktivität α-amylase variants with improved alkali activity |
| 07/19/2007 | DE102006001759A1 Synthesis of metal nanoparticles and nanocrystals, useful particularly for silver disinfection of e.g. medical instruments, uses a silicatein protein, also new silicateins and nucleic acid encoding them |
| 07/19/2007 | CA2637054A1 Epsp synthase enzyme domains conferring glyphosate resistance |
| 07/19/2007 | CA2636914A1 Oral composition containing interferon-.alpha. |
| 07/19/2007 | CA2636891A1 Luminescent stem cells and uses thereof |
| 07/19/2007 | CA2636888A1 Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof |
| 07/19/2007 | CA2636706A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration |
| 07/19/2007 | CA2636607A1 Nucleic acid molecules and collections thereof, their application and modification |
| 07/19/2007 | CA2636176A1 Novel efficient transformation method for sunflower and oil seeds based on positive selection |
| 07/19/2007 | CA2635972A1 Chimeric and humanised anti-human il-13 antibodies |
| 07/19/2007 | CA2633080A1 Method for preparing antibodies selective for activating fc receptors |
| 07/19/2007 | CA2632872A1 Use of stomatin (stm1) polynucleotides for achieving a pathogen resistance in plants |
| 07/18/2007 | EP1808496A1 Preparation of polynucleotide arrays |
| 07/18/2007 | EP1808495A1 Method and kit for detecting interactions between transcriptionally active proteins |
| 07/18/2007 | EP1808494A1 Electrochemically active compounds |
| 07/18/2007 | EP1808491A1 Genetically modified plant with modified storage protein content |
| 07/18/2007 | EP1808490A2 Genetically engineered bleb vaccine |
| 07/18/2007 | EP1808489A1 Expression system for Bacillus anthracis PA |
| 07/18/2007 | EP1808488A2 DNA sequences having anti-repressor activity |
| 07/18/2007 | EP1808487A1 Lactic acid bacterial starter cultures and compositions thereof |
| 07/18/2007 | EP1808486A1 Transgenic tomato plants with acquired resistance to pseudomonas syringae pv. tomato |
| 07/18/2007 | EP1808485A2 Mutants of lactobacillus casei defective in carbon catabolism regulation |
| 07/18/2007 | EP1808484A1 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/18/2007 | EP1808446A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 07/18/2007 | EP1808445A2 A receptor protein tyrosine kinase |
| 07/18/2007 | EP1808444A1 Amyloid beta protein (globular assembly and usees thereof) |
| 07/18/2007 | EP1808441A1 Luminescent stem cells, transgenic mammals and uses thereof |
| 07/18/2007 | EP1808407A1 Method of patterning self-organizing material, patterned substrate of self-organizing material and method of producing the same, and phosomask using patterned substrate of self-organizing material |
| 07/18/2007 | EP1808182A1 Lim mineralization protein splice variants |
| 07/18/2007 | EP1808180A2 Modified GP 100 and uses thereof |
| 07/18/2007 | EP1808168A1 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 07/18/2007 | EP1808161A1 Microprojectile delivery system and particulate product |
| 07/18/2007 | EP1808070A1 Animal model of neurodegenerative diseases, method of obtaining same and uses thereof |
| 07/18/2007 | EP1807701A2 Gpr17 modulators, method of screening and uses thereof |
| 07/18/2007 | EP1807697A1 Double hybrid system based on gene silencing by transcriptional interference |
| 07/18/2007 | EP1807538A2 Methods and kits for detecting germ cell genomic instability |
| 07/18/2007 | EP1807533A2 APPLICATIONS OF ISOLATED NUCLEIC ACID FRAGMENTS COMPRISING CpG ISLANDS |
| 07/18/2007 | EP1807527A2 High arachidonic acid producing strains of yarrowia lipolytica |
| 07/18/2007 | EP1807526A2 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 07/18/2007 | EP1807525A2 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 07/18/2007 | EP1807524A1 Baculovirus-based gene libraries |
| 07/18/2007 | EP1807523A2 Vesicle trafficking stress-related polypeptides and methods of use in plants |
| 07/18/2007 | EP1807522A2 Methods and materials for conferring resistance to pests and pathogens of plants |
| 07/18/2007 | EP1807521A1 Plants having improved growth characteristics and method for making the same |
| 07/18/2007 | EP1807520A2 Rna constructs |
| 07/18/2007 | EP1807519A1 Stress tolerant cotton plants |
| 07/18/2007 | EP1807518A1 Recombinant alpha-fetoprotein, method and means for preparation thereof, compositions on the base thereof and use thereof |
| 07/18/2007 | EP1807517A1 Bacterial vector |
| 07/18/2007 | EP1807516A2 Plant promoters and uses thereof |
| 07/18/2007 | EP1807515A2 Orthogonal translation components for the in vivo incorporation of unnatural amino acids |
| 07/18/2007 | EP1807514A1 Therapeutic rnai agents for treating psoriasis |
| 07/18/2007 | EP1807512A2 Compositions and methods for reverse transcription |
| 07/18/2007 | EP1807444A1 Pseudotyped baculovirus and its use |
| 07/18/2007 | EP1807207A1 Multiple cartridge and cartridge array frame |
| 07/18/2007 | EP1807157A2 Use of apoptosis inhibiting compounds in degenerative neurological disorders |
| 07/18/2007 | EP1806968A2 RNAi MODULATION OF RSV, PIV AND OTHER RESPIRATORY VIRUSES AND USES THEREOF |
| 07/18/2007 | EP1692285A4 Methods and means for altering fiber characteristics in fiber-producing plants |
| 07/18/2007 | EP1687418A4 Flp-mediated recombination |
| 07/18/2007 | EP1664343A4 Methods and compositions for generation of germline human antibody genes |
| 07/18/2007 | EP1552294A4 Systems and methods for constructing genomic-based phenotypic models |
| 07/18/2007 | EP1539236A4 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 07/18/2007 | EP1513923B1 Methods and materials for the production of d-lactic acid in yeast |